Icon
+91 94997 68112
Login Register

Canasa - (1gm; Suppository, Rectal)

Mesalamine Allergan
1gm; Suppository, Rectal
Less Than $1000 mn
Less Than 5
More Than 5
Less Than 5
Less Than 5
More Than 5
More Than 5
Indicated in adults for the treatment of mildly to moderately active ulcerative proctitis.
Yes
****** *** ***** *** ***** ** **** **** ** **** ******* '***, '*** **** ******** ** **** *, **** *** **** ************ *********. **** ***** *** ****** ******** ***** ***** ***** *** ******* **** *** ****** ** *** ********** *** ***** *********** **** ***** *** ****** *** ****** ***** ******** **** ********. ***** ****** ****** *** ************** ******** ******** ***** * **** ** **** *** **** ******* *** **** ************ *********. ********** *** ********* **** *****, ****** , ****** ****** *** ************** ******** ******** ***** *** ***** ** ********* *** *** *****. ***** ****** ***** **** ** **** *** **** ******* *** *** ************ ********* ***** ** ****** **** **** ****** ******* ** **** ****. ** *** ****, ***** ******** ******* **** *** **** ***********. *****, ****** ***** * **** ** *** *** *********. ** ****, **** ****** ****** *** ************** ******** ******** ******** *******. **** ****** *** ****** **** ******** ******* ***** ******* ********.
Canasa Patent 1 Patent 2
****** ******* *******
***** ******* *******
************** ******** ******** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** **, **** ******* ******** ******** ** *** *, ****
***** *** \ *** *** **, **** ******* ******** ******** ** *** **, ****
************** ******** ******** ** \ ** **** **, **** ******* ******** ******** ** **** *, ****
  1. *** **, **** : ******* ***** ******** ***** ******* ****** *** ***** ** *** *** ********* ***** **** ** **** ******* '***, '*** **** ******** ** **** *, ****.
  2. *** **, **** : ********** *** ********* **** ***** ***** *** ***** ** ********* *** *** *****.
  3. *** **, **** : ******* ***** * **** ******* ************** ******** ********.
  4. *** **, **** : ******* ***** * **** ******* ****** ****** ** ****** ****** ***** **** ** **** ******* '***, '*** **** ******** ** **** *, ****.
  5. *** **, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****.
  6. *** **, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****.
  7. *** **, **** : ********** *** ********* **** ************** ******** ******** ***** *** ***** ** ********* *** *** *****.
  8. *** **, **** : ***** ****** ******** ******* ***** *** **** ** **** ******* ‘*** *** *, ****, ‘****** *, ****, '*** (*** ** ******** ** **** *, ****)
  9. *** **, **** : ******* ***** * **** ******* ****** (*****) ** ******** ***** ** **.
  10. *** **, **** : ********** ********* ******* ***** **** ********** ******* **** ** **** ** ****** *** ******* ******* ********* ** **** **, ****, ** ******* ***** ******* *************.
  11. *** **, **** : ******* ***** * **** ******* ****** ****** ** ****** ****** ***** **** ** **** ******* '***, '*** **** ******** ** **** *, ****.
  12. *** **, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.